DOI:10.11952/j.issn.1007-1954.2021.01.015.XinPF,GaoX,KangFG,etal.ResearchprogressofRho/ROCKsignalingpathwayregulatinghepaticstellatecellactivation[J].Jour-nalofHepatopancreatobiliarySurgery,2021,33(1):61-65.DOI:10.11952/j.issn.1007-1954.2021.01.015.[17]陈烨,胡文慧,曾柱,等.柔软纤维蛋白水凝胶对活化态肝星状细胞转分化行为的影响[J].中山大学学报(医学版),2018,39(1):9-17.ChenY,HuWH,ZengZ,etal.Effectofsoftfibringelsontransdif-ferentiationbehaviourinactivatedhepaticstellatecell[J].JSUNYat-senUniv(MedSci),2018,39(1):9-17.[18]ZhangCY,YuanWG,HeP,etal.Liverfibrosisandhepaticstellatecells:etiology,pathologicalhallmarksandtherapeutictargets[J].WorldJGastroenterol,2016,22(48):10512-10522.DOI:10.3748/wjg.v22.i48.10512.[19]肖志勇,王晓临.纳米颗粒及天然产物治疗肝纤维化研究进展[J].中西医结合心血管病电子杂志,2021,8(36):28-29.[20]杨华蕊,徐妍,杨永寿,等.天然产物抗肝纤维化作用及其机制研究进展[J].中国实验方剂学杂志,2018,24(14):214-221.DOI:10.13422/j.cnki.syfjx.20181428.YangHR,XuY,YangYS,etal.Anti-hepaticfibrosiseffectandmechanismofnaturalproducts[J].ChineseJournalofExperimentalTraditionalMedicalFormulae,2018,24(14):214-221.DOI:10.13422/j.cnki.syfjx.20181428.[21]王哲,王佳贺.小白菊内酯药理作用的研究进展[J].中医药导报,2019,25(23):112-115.WangZ,WangJH.Advancesinstudiesonpharmacologicaleffectsofparthenolide[J].GuidingJournalofTraditionalChineseMedicineandPharmacy,2019,25(23):112-115.[22]张莹.小白菊内酯抑制腹膜透析相关性腹膜纤维化的实验研究[D].广州:南方医科大学,2020.ZhangY.Experimentalstudyofparthenolideinhibitingperitonealdi-alysis-relatedperitonealfibrosis[D].Guangzhou:SouthernMedicalUniversity,2020.[23]龙海波.一种化合物及其药物组合物在腹膜纤维化防治中的应用[P].2020.[24]钟祥龙.天然产物AinsliadimerA抑制HSP90抗前列腺癌机制研究[D].合肥:安徽中医药大学,2020.ZhongXL.MechanismofnaturalproductAinsliadimerAagainstpros-tatecancerbyinhibitingHSP90[D].Hefei:AnhuiUniversityofChineseMedicine,2020.[25]GaoZ,SuiJ,FanR,etal.Emodinprotectsagainstacutepancreatitis-associatedlunginjurybyinhibitingNLPR3inflammasomea...
